- Investing Ideas
- /
- Global Biotech Stocks
Global Biotech Stocks
Results
1455
0 new
Even though biotechnology stocks can be very risky, they can also offer some of the biggest rewards with huge profits on offer when you find the right one. The companies below all have reasonable balance sheets and value, giving the best chance of finding a gem.
1,455 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
LLY | US$786.23 | -1.4% | 33.5% | US$731.0b | US$991.89 | PE84.6x | E29.5% | 0.7% | ||
NOVO B | DKK 751.30 | 2.9% | 10.7% | DKK 3.3t | DKK 938.33 | PE35.1x | E14.3% | 1.3% | ||
JNJ | US$151.87 | -3.1% | 1.2% | US$368.9b | US$174.62 | PE24.8x | E10.3% | 3.3% | ||
ABBV | US$169.63 | -15.4% | 22.7% | US$301.0b | US$205.62 | PE59x | E27.7% | 3.9% | ||
MRK | US$98.36 | -2.8% | -3.6% | US$249.2b | US$131.72 | PE20.5x | E15.5% | 3.1% | ||
ROG | CHF 261.60 | -1.6% | 10.4% | CHF 210.3b | CHF 303.88 | PE19.6x | E11.1% | 3.7% | ||
NOVN | CHF 92.73 | -0.3% | 11.4% | CHF 185.4b | CHF 104.18 | PE17.7x | E7.0% | 3.4% | ||
TMO | US$533.02 | -4.1% | 12.8% | US$207.3b | US$656.23 | PE33.2x | E11.8% | 0.3% | ||
AZN | UK£102.92 | 5.8% | 1.2% | UK£159.6b | UK£141.77 | PE31.1x | E18.0% | 2.3% | ||
PFE | US$26.02 | -5.2% | -12.6% | US$151.4b | US$32.88 | PE34.5x | E16.8% | 6.5% | ||
VRTX | US$483.96 | -3.7% | 41.1% | US$127.4b | US$513.87 | PS11.7x | E47.2% | n/a | ||
SAN | €94.40 | -1.4% | 11.3% | €118.3b | €114.09 | PE26.3x | E17.9% | 4.0% | ||
BMY | US$58.50 | 6.9% | 15.1% | US$118.5b | US$58.64 | PS2.5x | E48.7% | 4.1% | ||
GILD | US$92.11 | -5.9% | 23.6% | US$115.4b | US$94.62 | PE911.1x | E40.7% | 3.3% | ||
CSL | AU$284.05 | 0.2% | 10.0% | AU$138.3b | AU$327.80 | PE33.6x | E13.0% | 1.4% | ||
REGN | US$782.51 | -5.1% | -1.8% | US$86.5b | US$1,082.63 | PE18.1x | E8.1% | n/a | ||
ZTS | US$174.63 | 0.2% | -1.1% | US$79.9b | US$214.78 | PE32.4x | E9.9% | 1.0% | ||
4519 | JP¥7,130.00 | 1.2% | 49.9% | JP¥11.7t | JP¥7,125.00 | PE30.3x | E6.0% | 1.2% | ||
GSK | UK£13.54 | -1.9% | -2.1% | UK£55.2b | UK£18.75 | PE22x | E22.4% | 4.3% | ||
MRK | €146.45 | -3.2% | -5.6% | €63.7b | €185.50 | PE24.2x | E10.7% | 1.5% | ||
4568 | JP¥4,551.00 | -6.5% | 14.8% | JP¥8.6t | JP¥6,452.94 | PE34.4x | E20.2% | 1.3% | ||
4502 | JP¥4,213.00 | -0.5% | 1.6% | JP¥6.7t | JP¥4,777.17 | PE23x | E11.8% | 4.7% | ||
A | US$130.22 | -6.7% | 14.0% | US$38.6b | US$150.11 | PE26.5x | E4.1% | 0.7% | ||
ARGX | €568.20 | 3.5% | 26.3% | €34.0b | €559.36 | PS18.7x | E56.8% | n/a |